TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Insurers Press for Tighter Oversight Insurance-industry executives are urging state regulators to thwart what they call widening efforts by professional investors to use various consumer products to turn a profit. online.wsj.com |
Doctors Slam Insurers Over Rankings Doctor groups criticized growing efforts by health plans to steer patients toward certain physicians based on cost or quality, arguing in a letter to insurers that the rankings may be unreliable and unfair. online.wsj.com |
Is Lorcaserin the New Miracle Drug? KLLJ Investments submits: The 15th century Italian philosopher Machievelli wrote: Whoever wishes to foresee the future must consult the past; for human events ever resemble those of preceding times. This arises from the fact that they are produced by men who ever have been, and ever shall be, animated by the same passions, and thus they necessarily have the same results.Complete Story » seekingalpha.com |
BioClinica Responds to Shareholder Letter [Business Wire] - NEWTOWN, Pa.----BioClinicaâ„¢, Inc. , a global provider of clinical trial management services, has issued the following statement: us.rd.yahoo.com |
Acorda Hopes to Meet Huge Need in Challenging Stroke Market Douglas Cress submits:By vandersonTime is critical when a patient suffers from a stroke. Approximately 87 percent of strokes are caused by blood clots blocking blood flow to the brain, a condition known as ischemic stroke. The drug tPA can restore normal blood flow, but physicians only have a brief window of opportunity—just a few hours from the first symptom—to treat the patient. Furthermore, only 3 to 5 percent of patients are eligible for this treatment option. According to a recent USA Today article, only about a third of stroke sufferers reach the hospital in time for testing to determine their eligibility for tPA therapy. In the United States, stroke affects approximately 800,000 people each year. It is the third leading cause of death as well as the leading cause of disability in the U.S. In many cases, the patient survives but suffers permanent disability or neurological damage. The American Stroke Association estimates that Americans will pay about $73.7 billion in 2010 for stroke-related medical costs and disability. The clinical need is clear: Patients who suffer an ischemic stroke but do not reach the hospital in time to qualify for tPA therapy desperately need a pharmacological alternative. Complete Story » seekingalpha.com |